focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,937.00
Bid: 1,936.00
Ask: 1,939.00
Change: 5.00 (0.26%)
Spread: 3.00 (0.155%)
Open: 1,926.00
High: 1,948.00
Low: 1,904.00
Prev. Close: 1,932.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 14th Feb 2013 08:09

African Barrick Gold: Deutsche Bank cuts target price from 410p to 340p, while staying with its hold recommendation. Investec reduces target price from 405p to 315p and downgrades from buy to hold. JP Morgan lowers target price from 370p to 290p and downgrades to underweight.AG Barr: Barclays downgrades to equal-weight. Canaccord Genuity downgrades to hold with a target price of 490p.ASOS: HSBC raises target price from 2750p to 3530p and upgrades to overweight.Barclays: Deutsche Bank revises target price from 360p to 380p maintaining a buy recommendation. Investec moves target price from 320p to 340p, while downgrading from buy to hold.Brown (N) Group: HSBC takes target price from 420p to 430p reiterating an overweight rating.Britvic: Barclays cuts to equal-weight. JP Morgan lowers target price from 400p to 380p and downgrades to underperform.Daily Mail and General Trust: UBS raises target price from 520p to 650p maintaining a neutral rating.Euromoney Institutional Investor: UBS increases target price from 775p to 900p and retains a neutral rating.FlyBe: HSBC lowers target price from 80p to 70p and retains an overweight rating.Gulfsands Petroleum: Cantor Fitzgerald (formerly Seymour Pierce) reduces target price from 366p to 162p and keeps a buy recommendation.G4S: Investec revises target price from 280p to 330p and upgrades from hold to buy.Halma: Investec increases target price from 515p to 550p keeping a buy recommendation.Hikma: Panmure Gordon ups target price from 825p to 930p, while leaving its buy recommendation unchanged.JSC Bank of Georgia Holdings: Citigroup downgrades to neutral with a target price of 1500p.Laird: JP Morgan moves target price from 281p to 291p reiterating an overweight rating. Numis increases target price from 250p to 310p and stays with its buy recommendation.McBride: Investec shifts target price from 150p to 154p and maintains a buy rating.Morgan Crucible: Investec ups target price from 295p to 370p and leaves its buy recommendation unchanged.Newmark Security: Cantor Fitzgerald (formerly Seymour Pierce) moves target price from 1.50p to 2.00p maintaining a buy recommendation.Next: HSBC increases target price from 4100p to 4965p upgrading to overweight.Norcros: Numis downgrades to add with a target price of 20p.Oxford Instruments: JP Morgan takes target price from 1500p to 1750p and leaves its overweight rating unchanged.Reckitt Benckiser: Deutsche Bank ups target price from 4600p to 4800p and stays with its buy recommendation. Credit Suisse raises target price from 3700p to 4000p retaining a neutral rating. Nomura increases target price from 4800p to 4900p, while its buy recommendation is kept. Oriel Securities moves target price from 3730p to 4700p upgrading to add.Rolls-Royce Group: Investec downgrades from buy to add with its target price at 1005p.Salamander Energy: Investec revises target price from 200p to 250p and upgrades from hold to buy.SOCO International: Exane BNP lowers target price from 405p to 390p, while leaving its neutral rating unaltered.Spirent Communications: Panmure Gordon shifts target price from 184p to 192p and keeps a buy recommendation.SVG Capital: Oriel Securities shifts target price from 360p to 370p, while its buy recommendation is kept.Synergy Health: Investec raises target price from 1048p to 1105p, while downgrading from buy to add.Telecity Group: Investec ups target price from 750p to 1000p and upgrades from hold to buy. UBS revises target price from 945p to 1000p reiterating a buy recommendation.Tullow Oil: Deutsche Bank reduces target price from 1105p to 1075p keeping a hold recommendation. Credit Suisse cuts target price from 1450p to 1350p, while its neutral rating remains unchanged. Nomura lowers target price from 1350p to 1330p and retains a reduce rating.Whitbread: Investec increases target price from 1650p to 2000p, but still recommends selling.
More News
27 Sep 2021 09:31

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

Read more
27 Sep 2021 09:28

UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...

Read more
27 Sep 2021 08:50

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

Read more
27 Sep 2021 08:16

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

Read more
27 Sep 2021 07:49

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
13 Sep 2021 16:09

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
2 Sep 2021 09:38

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Read more
27 Aug 2021 12:32

Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody

(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.

Read more
20 Aug 2021 09:46

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

Read more
20 Aug 2021 08:10

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

Read more
17 Aug 2021 09:46

UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK employment closer to pre-pandemic levels* BHP Group jumps on strong results* PLUS500 gains on robust revenue forecasts* FTSE 100 up 0.3%...

Read more
12 Aug 2021 16:04

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
6 Aug 2021 17:06

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.